Okati-Aliabad H, Ansari-Moghaddam A, Kargar S, Jabbari N. Prevalence of obesity and overweight among adults in the middle east countries from 2000 to 2020: a systematic review and meta-analysis. Journal of obesity. 2022;2022.

Moreno L, Chirita-Emandi A, Ali M, de Leon A, Cacciottolo J, D’’Arrigo G et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. 2017.

Dai H, Alsalhe TA, Chalghaf N, Riccò M, Bragazzi NL, Wu J. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: an analysis of the global burden of Disease Study. PLoS Med. 2020;17(7):e1003198.

Article  PubMed  PubMed Central  Google Scholar 

Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Global Health. 2022;7(9):e009773.

Article  PubMed  PubMed Central  Google Scholar 

Flodgren G, Gonçalves-Bradley DC, Summerbell CD. Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity. Cochrane Database Syst Reviews. 2017 (11).

Mehta M, Istfan NW, Apovian CM. Obesity: overview of weight management. Endocr Pract. 2021;27(6):626–35.

Article  PubMed  Google Scholar 

Reis MG, Moreira LFGG, de Andrade Carvalho LSV, de Castro CT, Vieira RAL, Guimarães NS. Weight regain after bariatric surgery: a systematic review and meta-analysis of observational studies. Obes Med. 2023:100528.

Machado AM, Guimarães NS, Bocardi VB, da Silva TPR, do, Carmo AS, de Menezes MC et al. Understanding weight regain after a nutritional weight loss intervention: systematic review and meta-analysis. Clinical nutrition ESPEN. 2022;49:138 – 53.

Wu Q-J, Zhang T-N, Chen H-H, Yu X-F, Lv J-L, Liu Y-Y, et al. The sirtuin family in health and disease. Signal Transduct Target Therapy. 2022;7(1):402.

Article  CAS  Google Scholar 

Sanders BD, Jackson B, Marmorstein R. Structural basis for sirtuin function: what we know and what we don’t. Biochim et Biophys Acta (BBA)-Proteins Proteom. 2010;1804(8):1604–16.

Article  CAS  Google Scholar 

Avilkina V, Chauveau C, Mhenni OG. Sirtuin function and metabolism: role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis. Bone. 2022;154:116232.

Article  CAS  PubMed  Google Scholar 

Chen J, Lin L, Sirtuins. Key players in obesity-associated adipose tissue remodeling. Front Immunol. 2022;13:1068986.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxidative medicine and cellular longevity. 2020;2020.

Zhou S, Tang X, Chen H-Z. Sirtuins and insulin resistance. Front Endocrinol. 2018;9:421838.

Article  Google Scholar 

Xu J, Jackson CW, Khoury N, Escobar I, Perez-Pinzon MA. Brain SIRT1 mediates metabolic homeostasis and neuroprotection. Front Endocrinol. 2018;9:419884.

Article  Google Scholar 

Iside C, Scafuro M, Nebbioso A, Altucci L. SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol. 2020;11:551744.

Article  Google Scholar 

Nandave M, Acharjee R, Bhaduri K, Upadhyay J, Rupanagunta GP, Ansari MN. A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: call for further research. Int J Biol Macromol. 2023:124581.

Lu C, Zhao H, Liu Y, Yang Z, Yao H, Liu T, et al. Novel role of the SIRT1 in endocrine and metabolic diseases. Int J Biol Sci. 2023;19(2):484.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduct Target Therapy. 2022;7(1):298.

Article  Google Scholar 

Shen S, Shen M, Kuang L, Yang K, Wu S, Liu X et al. SIRT1/SREBPs-mediated regulation of lipid metabolism. Pharmacol Res. 2023:107037.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Reviews. 2015;4(1):1.

Article  Google Scholar 

Higgins J, Wells G. Cochrane handbook for systematic reviews of interventions. 2011.

Schwingshackl L, Knüppel S, Schwedhelm C, Hoffmann G, Missbach B, Stelmach-Mardas M, et al. Perspective: NutriGrade: a Scoring System to assess and judge the Meta-evidence of Randomized controlled trials and Cohort studies in Nutrition Research. Adv Nutr. 2016;7(6):994–1004. PubMed PMID: 28140319. eng.

Article  PubMed  PubMed Central  Google Scholar 

Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www cochrane-handbook org. 2011.

Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

Article  PubMed  PubMed Central  Google Scholar 

Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y-R, Lai Y-l, Lin S-d, Li X-t, Fu Y-C, Xu W-C. SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats. Mol Biol Rep. 2013;40:3373–80.

Article  CAS  PubMed  Google Scholar 

Mariani S, Costantini D, Lubrano C, Basciani S, Caldaroni C, Barbaro G, et al. Circulating SIRT1 inversely correlates with epicardial fat thickness in patients with obesity. Nutr Metabolism Cardiovasc Dis. 2016;26(11):1033–8.

Article  CAS  Google Scholar 

Li Y, Ni J, Guo R, Li W. In patients with coronary artery disease and type 2 diabetes, SIRT1 expression in circulating mononuclear cells is associated with levels of inflammatory cytokines but not with coronary lesions. BioMed research international. 2016;2016.

de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Man CD, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes. 2010;59(4):1006–15.

Article  PubMed  PubMed Central  Google Scholar 

Xu F, Gao Z, Zhang J, Rivera CA, Yin J, Weng J, et al. Lack of SIRT1 (mammalian sirtuin 1) activity leads to liver steatosis in the SIRT1+/– mice: a role of lipid mobilization and inflammation. Endocrinology. 2010;151(6):2504–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kotas ME, Gorecki MC, Gillum MP. Sirtuin-1 is a nutrient-dependent modulator of inflammation. Adipocyte. 2013;2(2):113–8.

Article  PubMed  PubMed Central  Google Scholar 

Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21(11):1559–73.

Article  PubMed  Google Scholar 

Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:1–12.

Article  Google Scholar 

Opstad TB, Sundfør T, Tonstad S, Seljeflot I. Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index. Nutr Metabolism Cardiovasc Dis. 2021;31(6):1871–8.

Article  CAS  Google Scholar